Clinical Trial

Onyx™ Liquid Embolic IDE Clinical Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11 -> 2027-04 2026-05-02
minor Completion pushed: 2026-12 -> 2027-05 2026-05-02
Trial Details
NCT Number NCT06742801
Lead Sponsor Medtronic Endovascular
Conditions Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer, Hemorrhage
Enrollment 119 participants
Start Date 2025-05-09
Primary Completion 2027-04 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-24